FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34345811000001102: Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
103908001000001114 Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103908101000001110 Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Is a Baricitinib 4mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Has AMP Olumiant 4mg tablets (Eli Lilly and Company Ltd) true Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Baricitinib false Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Baricitinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start